These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 12497580

  • 1. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
    Fixemer T, Remberger K, Bonkhoff H.
    Prostate; 2003 Feb 01; 54(2):79-87. PubMed ID: 12497580
    [Abstract] [Full Text] [Related]

  • 2. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
    Walton TJ, Li G, McCulloch TA, Seth R, Powe DG, Bishop MC, Rees RC.
    Prostate; 2009 Jun 01; 69(8):810-9. PubMed ID: 19189301
    [Abstract] [Full Text] [Related]

  • 3. Metastases of prostate cancer express estrogen receptor-beta.
    Lai JS, Brown LG, True LD, Hawley SJ, Etzioni RB, Higano CS, Ho SM, Vessella RL, Corey E.
    Urology; 2004 Oct 01; 64(4):814-20. PubMed ID: 15491740
    [Abstract] [Full Text] [Related]

  • 4. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Bostwick DG.
    J Urol; 1999 Apr 01; 161(4):1229-32. PubMed ID: 10081875
    [Abstract] [Full Text] [Related]

  • 5. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
    Väisänen MR, Väisänen T, Jukkola-Vuorinen A, Vuopala KS, Desmond R, Selander KS, Vaarala MH.
    Prostate; 2010 Jun 01; 70(8):817-24. PubMed ID: 20054821
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Frequent loss of estrogen receptor-beta expression in prostate cancer.
    Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Stricker PD, Grygiel JJ, Gustafsson JA, Sutherland RL.
    Cancer Res; 2001 Jul 15; 61(14):5331-5. PubMed ID: 11454669
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
    Wang M, Pan JY, Song GR, Chen HB, An LJ, Qu SX.
    Eur J Surg Oncol; 2007 Mar 15; 33(2):195-201. PubMed ID: 17046193
    [Abstract] [Full Text] [Related]

  • 10. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
    Ryan CJ, Haqq CM, Simko J, Nonaka DF, Chan JM, Weinberg V, Small EJ, Goldfine ID.
    Urol Oncol; 2007 Mar 15; 25(2):134-40. PubMed ID: 17349528
    [Abstract] [Full Text] [Related]

  • 11. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T, Herawi M, Epstein JI, Illei PB.
    Am J Surg Pathol; 2007 Sep 15; 31(9):1351-5. PubMed ID: 17721190
    [Abstract] [Full Text] [Related]

  • 12. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
    Rubin MA, Mucci NR, Figurski J, Fecko A, Pienta KJ, Day ML.
    Hum Pathol; 2001 Jul 15; 32(7):690-7. PubMed ID: 11486167
    [Abstract] [Full Text] [Related]

  • 13. Expression of ERalpha and ERbeta in prostate cancer.
    Linja MJ, Savinainen KJ, Tammela TL, Isola JJ, Visakorpi T.
    Prostate; 2003 May 15; 55(3):180-6. PubMed ID: 12692783
    [Abstract] [Full Text] [Related]

  • 14. Differential expression of estrogen receptor beta (ERbeta) and its C-terminal truncated splice variant ERbetacx as prognostic predictors in human prostatic cancer.
    Fujimura T, Takahashi S, Urano T, Ogawa S, Ouchi Y, Kitamura T, Muramatsu M, Inoue S.
    Biochem Biophys Res Commun; 2001 Dec 07; 289(3):692-9. PubMed ID: 11726203
    [Abstract] [Full Text] [Related]

  • 15. Estrogen receptor expression in prostate cancer and premalignant prostatic lesions.
    Bonkhoff H, Fixemer T, Hunsicker I, Remberger K.
    Am J Pathol; 1999 Aug 07; 155(2):641-7. PubMed ID: 10433957
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma.
    Collett GP, Betts AM, Johnson MI, Pulimood AB, Cook S, Neal DE, Robson CN.
    Clin Cancer Res; 2000 Aug 07; 6(8):3241-8. PubMed ID: 10955810
    [Abstract] [Full Text] [Related]

  • 19. CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells.
    Chen M, Ni J, Chang HC, Lin CY, Muyan M, Yeh S.
    Carcinogenesis; 2009 May 07; 30(5):841-50. PubMed ID: 19126643
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.